-
Mashup Score: 8Simple medical device improves care after kidney transplantation - 3 year(s) ago
/PRNewswire/ — In a published study, a team from Lawson Health Research Institute (LHSC), in Ontario Canada, has found that a simple medical device can reduce…
Source: www.prnewswire.co.ukCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0Medicxi Announces Departure of Dr. Moncef Slaoui - 3 year(s) ago
/PRNewswire/ — Medicxi announces that Dr Moncef Slaoui has stepped down from his position as a Partner at Medicxi with immediate effect. This follows the…
Source: www.prnewswire.co.ukCategories: Healthcare Professionals, Latest HeadlinesTweet-
Medicxi Announces Departure of Dr. Moncef Slaoui https://t.co/eAZt0AP5Cp
-
-
Mashup Score: 0
/PRNewswire/ — Ernst & Young, a global leader in advisory services, published a report on how to create the right data environment for a connected health…
Source: www.prnewswire.co.ukCategories: Future of Medicine, Latest HeadlinesTweet-
Better reveals how #DigitalTransformation can improve the work of medical teams https://t.co/187bW9th9Q https://t.co/1JhmUNOpvn
-
-
Mashup Score: 0
/PRNewswire/ — New recommendations from a panel of globally recognized medical and scientific experts say that by relentlessly focusing on prevention and…
Source: www.prnewswire.co.ukCategories: Healthcare Professionals, Latest HeadlinesTweet-
Experts recommend heightened protocols for the healthy return of sailing https://t.co/SD9g5GE8ab
-
-
Mashup Score: 0Technology Empowers Ping An's Health Care Amid Coronavirus - 4 year(s) ago
/PRNewswire/ — Jessica Tan, Co-CEO of Ping An Insurance (Group) Company of China, Ltd. (hereafter “Ping An” or the “Group”, HKEx:2318; SSE:601318), spoke at…
Source: www.prnewswire.co.ukCategories: Healthcare Professionals, Latest HeadlinesTweet-
Technology Empowers #PingAn #Healthcare Amid #Coronavirus | #covid19 https://t.co/p0XObCBYDp
-
-
Mashup Score: 2
/PRNewswire/ — Global biotherapeutics leader CSL Behring announced today that the European Medicines Agency (EMA) has approved the new Summary of Product…
Source: www.prnewswire.co.ukCategories: Hem/Oncs, Latest HeadlinesTweet-
The European Medicines Agency has approved Idelvion as prophylaxis in #haemophilia B every 21 days. Idelvion is recombinant FIX linked to albumin and is an extended half life product. So far EHL FIXs have been approved for up to 14 day administration. https://t.co/zwb0WZmMfN
-
-
Mashup Score: 0
/PRNewswire/ — Valo Therapeutics Limited (Valo Tx), an immuno-oncology company developing tumour antigen-coated oncolytic viruses as therapeutic vaccines,…
Source: www.prnewswire.co.ukCategories: Hem/OncsTweet-
Another future clinical trial in #melanoma and other #cancers, examining a novel adenovirus "coated" with hopefully effectively immunogenic proteins: https://t.co/bCtfCaMBdh
-
Here is a nice study showing the benefits of using a simple medical device that improves care after kidney transplantation. It was a clinical trial (n=221), not just a PR announcement about the new tech. It reduced surgical site infections by almost 60%. 👉https://t.co/ygXPK3X886 https://t.co/JHIuRvGgVA